UNLABELLED: The paracellular cleft within epithelia/endothelia is sealed by tight junction (TJ) proteins. Their extracellular loops (ECLs) are assumed to control paracellular permeability and are targets of pathogenes. We demonstrated that claudin-1 is crucial for paracellular tightening. Its ECL1 is essential for the sealing and contains two cysteines conserved throughout all claudins. AIMS: We prove the hypothesis that this cysteine motif forms a redox-sensitive intramolecular disulfide bridge and, hence, the claudin-1-ECL1 constitutes a functional structure which is associated to ECLs of this and other TJ proteins. RESULTS: The structure and function of claudin-1-ECL1 was elucidated by investigating sequences of this ECL as synthetic peptides, C1C2, and as recombinant proteins, and exhibited a β-sheet binding surface flanked by an α-helix. These sequences bound to different claudins, their ECL1, and peptides with nanomolar binding constants. C-terminally truncated C1C2 (-4aaC) opened cellular barriers and the perineurium. Recombinant ECL1 formed oligomers, and bound to claudin-1 expressing cells. Oligomerization and claudin association were abolished by reducing agents, indicating intraloop disulfide bridging and redox sensitivity. INNOVATION: The structural and functional model based on our in vitro and in vivo investigations suggested that claudin-1-ECL1 constitutes a functional and ECL-binding β-sheet, stabilized by a shielded and redox-sensitive disulfide bond. CONCLUSION: Since the β-sheet represents a consensus sequence of claudins and further junctional proteins, a general structural feature is implied. Therefore, our model is of general relevance for the TJ assembly in normal and pathological conditions. C1C2-4aaC is a new drug enhancer that is used to improve pharmacological treatment through tissue barriers.
UNLABELLED: The paracellular cleft within epithelia/endothelia is sealed by tight junction (TJ) proteins. Their extracellular loops (ECLs) are assumed to control paracellular permeability and are targets of pathogenes. We demonstrated that claudin-1 is crucial for paracellular tightening. Its ECL1 is essential for the sealing and contains two cysteines conserved throughout all claudins. AIMS: We prove the hypothesis that this cysteine motif forms a redox-sensitive intramolecular disulfide bridge and, hence, the claudin-1-ECL1 constitutes a functional structure which is associated to ECLs of this and other TJ proteins. RESULTS: The structure and function of claudin-1-ECL1 was elucidated by investigating sequences of this ECL as synthetic peptides, C1C2, and as recombinant proteins, and exhibited a β-sheet binding surface flanked by an α-helix. These sequences bound to different claudins, their ECL1, and peptides with nanomolar binding constants. C-terminally truncated C1C2 (-4aaC) opened cellular barriers and the perineurium. Recombinant ECL1 formed oligomers, and bound to claudin-1 expressing cells. Oligomerization and claudin association were abolished by reducing agents, indicating intraloop disulfide bridging and redox sensitivity. INNOVATION: The structural and functional model based on our in vitro and in vivo investigations suggested that claudin-1-ECL1 constitutes a functional and ECL-binding β-sheet, stabilized by a shielded and redox-sensitive disulfide bond. CONCLUSION: Since the β-sheet represents a consensus sequence of claudins and further junctional proteins, a general structural feature is implied. Therefore, our model is of general relevance for the TJ assembly in normal and pathological conditions. C1C2-4aaC is a new drug enhancer that is used to improve pharmacological treatment through tissue barriers.
Authors: Oscar R Colegio; Christina M Van Itallie; Heather J McCrea; Christoph Rahner; James Melvin Anderson Journal: Am J Physiol Cell Physiol Date: 2002-07 Impact factor: 4.249
Authors: Christian Bellmann; Sophie Schreivogel; Ramona Günther; Sebastian Dabrowski; Michael Schümann; Hartwig Wolburg; Ingolf E Blasig Journal: Antioxid Redox Signal Date: 2013-09-17 Impact factor: 8.401
Authors: Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice Journal: Nature Date: 2009-01-28 Impact factor: 49.962
Authors: Philipp Berndt; Lars Winkler; Jimmi Cording; Olga Breitkreuz-Korff; André Rex; Sophie Dithmer; Valentina Rausch; Rosel Blasig; Matthias Richter; Anje Sporbert; Hartwig Wolburg; Ingolf E Blasig; Reiner F Haseloff Journal: Cell Mol Life Sci Date: 2019-02-07 Impact factor: 9.261
Authors: Fei Liu; Michael Koval; Shoba Ranganathan; Susan Fanayan; William S Hancock; Emma K Lundberg; Ronald C Beavis; Lydie Lane; Paula Duek; Leon McQuade; Neil L Kelleher; Mark S Baker Journal: J Proteome Res Date: 2016-01-12 Impact factor: 4.466
Authors: Nora Gehne; Agathe Lamik; Martin Lehmann; Reiner F Haseloff; Anuska V Andjelkovic; Ingolf E Blasig Journal: PLoS One Date: 2017-08-15 Impact factor: 3.240
Authors: Barbara Schlingmann; Christian E Overgaard; Samuel A Molina; K Sabrina Lynn; Leslie A Mitchell; StevenClaude Dorsainvil White; Alexa L Mattheyses; David M Guidot; Christopher T Capaldo; Michael Koval Journal: Nat Commun Date: 2016-07-25 Impact factor: 14.919
Authors: Egle M Mambretti; Katrin Kistner; Stefanie Mayer; Dominique Massotte; Brigitte L Kieffer; Carsten Hoffmann; Peter W Reeh; Alexander Brack; Esther Asan; Heike L Rittner Journal: Mol Pain Date: 2016-03-01 Impact factor: 3.395